Acute Pain Episodes in Patients Under Opioid Maintenance Therapy : Clinical Management and Long Term Effects
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00738036|
Recruitment Status : Completed
First Posted : August 20, 2008
Last Update Posted : May 12, 2017
To define a rational pharmacological management of pain for the subjects under opioid maintenance therapy (methadone or buprenorphine), it is first of all necessary to estimate the efficiency of the current practices on pain management as well as their potentially noxious consequences, in particular on the long term opioid maintenance therapy.
The objective of the study is to compare the efficiency of the opioid maintenance therapy according to the arisen of an acute painful phenomenon requiring an analgesic management for these patients. At first, this work will allow to determine the results on acute pain of the current practices for these patients. The comparison of the long term consequences on opioid maintenance therapy between the patients that presented an acute painful phenomenon and the control patients should help to improve acute pain management for these patients while limiting the risk of relapse in the abused consumption of psychoactive substances.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||151 participants|
|Official Title:||Acute Pain Episodes in Patients Under Opioid Maintenance Therapy : Clinical Management and Long Term Effects|
|Study Start Date :||April 2008|
|Actual Primary Completion Date :||November 2009|
|Actual Study Completion Date :||November 2009|
Exposed to an acute painful phenomenon requiring an analgesic management
Control, not exposed to acute pain
- Retention rate under buprenorphine or methadone treatment defined as the percentage of patients still under treatment during the follow-up [ Time Frame: 1, 3, 6 and 12 months ]
- pain, anxiety, drugs, alcohol and other substances abuse and dependence, drug prescription (included for pain treatment and opioid maintenance) [ Time Frame: 1, 3, 6 and 12 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00738036
|University Hospital Toulouse|
|Toulouse, France, 31059|
|Study Director:||Maryse Lapeyre-Mestre, MD||University Hospital, Toulouse|